FTC Warns On Misleading TV Ads By Personal Injury Lawyers
Legal service ads that attempt to recruit patient plaintiffs for product-safety lawsuits against drug and device companies by resembling official medical alerts or recall notices may be deceptive or unfair, the US Federal Trade Commission warned in a recent set of letters.
You may also be interested in...
Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.
The US Patent Office has rejected a request by Edwards Lifesciences to review an Abbott patent on heart-valve technology, which could establish the patent as a key part of Abbott Laboratories’ arguments in a larger ongoing intellectual property case.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.